Intel Rises, Mission Produce Drops, Tango Therapeutics Surges

Today's biggest winners and losers in the stock market, a look at the notable movers:

On this episode of Stock Movers:
- Intel (INTC) shares rose after the Information reported that Alphabet Inc.'s Google will rely on it for more than 3 million specialized AI chips in 2028. Google decided to tap Intel to make some of its tensor processing units — TPUs for short — after months of testing the chipmaker’s technology, the Information said Monday, citing two unnamed sources.

- Mission Produce (AVO) swung to a loss and reported lower revenue in the fiscal second quarter due to low avocado prices and harvest delays. The company reported a loss and lower revenue, but volumes grew and supply conditions have improved with better pricing and margins since the second quarter.

- Tango Therapeutics (TNGX) jumped as much as 48% after initial results of a study showed a combination of its drug and a Revolution Medicines Inc. medicine shrunk tumors in advanced pancreatic cancer patients. Tumor size decreased significantly in 11 of 12 pancreatic cancer patients who received the two-drug combination, Tango said in a statement Monday. The data includes two people whose responses had not yet been confirmed by a second scan. The biotech company said that it plans to begin a final stage trial combining its drug, vopimetostat, with Revolution’s daraxonrasib for the initial treatment of advanced pancreatic cancer.

See omnystudio.com/listener for privacy information.